Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2768784 | Revista Española de Anestesiología y Reanimación | 2013 | 9 Pages |
Abstract
With these results, we cannot recommend the routine use of carbetocin in caesarean sections, because it is accompanied by an increased incidence of side effects without any improvement in the prevention of obstetric haemorrhage. Finally, it is economically more expensive than the use of low doses of oxytocin, which may be the trend that should be considered in the future, due to the clinical outcomes, and its lower cost.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
J.R. Ortiz-Gómez, F. Morillas-RamÃrez, I. Fornet-Ruiz, F.J. Palacio-Abizanda, L. Bermejo-Albares,